Sector Gamma ASA »

Alkermes shares owned by Sector Gamma ASA

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Sector Gamma ASA from 13F filings

Historical chart of Sector Gamma ASA investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Sector Gamma ASA

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.5M 200k 27.74

More positions owned by Sector Gamma ASA

Medtronic SHS (MDT)
Pfizer (PFE)
Gilead Sciences (GILD)
Biogen Idec (BIIB)
Incyte Corporation (INCY)
Bristol Myers Squibb (BMY)
Ge Healthcare Technologies I Common Stock (GEHC)
CVS Caremark Corporation (CVS)
Zimmer Holdings (ZBH)
Cardinal Health (CAH)
Centene Corporation (CNC)
Tenet Healthcare Corp Com New (THC)
Edwards Lifesciences (EW)
Anthem (ELV)
Baxter International (BAX)

View all positions for Sector Gamma ASA

Top funds holding Alkermes

Vanguard Group
Wellington Management Company
Johnston Asset Management Corp.
PRIMECAP Management Company
Bank of New York Mellon
Dimensional Fund Advisors
Charles Schwab Investment Management
Artisan Partners Limited Partnership
Norges Bank Investment Management
Westfield Capital Management Company
T. Rowe Price Associates
Jupiter Asset Management
Goldman Sachs Group
Bank of America Corporation
Jacobs Levy Equity Management

View all funds holding Alkermes